J S Lee
The University of Texas MD Anderson Cancer Center · 4 works · 671 citations · h-index 4
Top works
- Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.
- Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.
- Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852.
- Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.